Fig. 2From: Real-time molecular optical micro-imaging of EGFR mutations using a fluorescent erlotinib based tracerMTT viability assay for each cell line to increasing concentrations of erlotinib, tracer and DMSO. Results are expressed in percentage of cell alive to increasing concentrations of tracer, erlotinib and control (DMSO) (ns = not significant)Back to article page